McKinsey to Pay $650 Million to Settle Opioid Crisis Probe
McKinsey & Company will pay $650 million to settle a federal investigation into its role in boosting OxyContin sales for Purdue Pharma. This settlement avoids criminal charges but requires McKinsey to cease work related to controlled substances for five years. Former McKinsey senior partner Martin Elling pleaded guilty to obstruction of justice for destroying relevant documents. The Justice Department alleges McKinsey knowingly aided Purdue Pharma in unsafe and unethical sales practices, contributing to the opioid crisis.
John Q. Hosedrinker